Reference
1. Bulat V, Lugovic L, Situm M, Buljan M , Bradic L. Porphyria cutanea tarda as the most common porphyria. Acta Dermatovenerol Croat 2007;15:254-63.
2. Singal AK. Porphyria cutanea tarda: Recent update. Mol Genet Metab 2019;128:271-81.
3. Frank J , Poblete-Gutierrez P. Porphyria cutanea tarda–when skin meets liver. Best Pract Res Clin Gastroenterol 2010;24:735-45.
4. Mondal AK, Kumar P , Gharami RC. A baby with photosensitivity and red teeth. Indian Dermatol Online J 2013;4:260-1.
5. Ryan Caballes F, Sendi H , Bonkovsky HL. Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int 2012;32:880-93.
6. Pagnotta PA, Melito VA, Lavandera JV, Parera VE, Rossetti MV, Zuccoli JR et al. Role of ABCB1 and glutathione S-transferase gene variants in the association of porphyria cutanea tarda and human immunodeficiency virus infection. Biomed Rep 2021;14:22.
7. Gibson GE , McEvoy MT. Coexistence of lupus erythematosus and porphyria cutanea tarda in fifteen patients. J Am Acad Dermatol 1998;38:569-73.
8. Seubert S, Seubert A, Rumpf KW , Kiffe H. A porphyria cutanea tarda-like distribution pattern of porphyrins in plasma, hemodialysate, hemofiltrate, and urine of patients on chronic hemodialysis. J Invest Dermatol 1985;85:107-9.
9. Elder GH. Alcohol intake and porphyria cutanea tarda. Clin Dermatol 1999;17:431-6.
10. Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 2006;65:278-90.
11. Christiansen AL, Brock A, Bygum A, Rasmussen LM , Jepsen P. Increased mortality in patients with porphyria cutanea tarda-A nationwide cohort study. J Am Acad Dermatol 2020;83:817-23.
12. Vieira FM, Nakhle MC, Abrantes-Lemos CP, Cancado EL , Reis VM. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients. An Bras Dermatol 2013;88:530-40.
13. Kowdley KV, Brown KE, Ahn J , Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis. Am J Gastroenterol 2019;114:1202-18.
14. Singal AK, Kormos-Hallberg C, Lee C, Sadagoparamanujam VM, Grady JJ, Freeman DH, Jr. et al. Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda. Clin Gastroenterol Hepatol 2012;10:1402-9.
15. Kowertz MJ. The therapeutic effect of chloroquine. Hepatic recovery in porphyria cutanea tarda. JAMA 1973;223:515-9.